cannabinoid Coverage - MedCity News https://medcitynews.com/tag/cannabinoid/ Healthcare technology news, life science current events Thu, 13 Jun 2024 18:42:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 228111745 Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program https://medcitynews.com/2024/06/skye-bioscience-cb1-glaucoma-obesity-weight-loss-metabolic-nimacimab/ https://medcitynews.com/2024/06/skye-bioscience-cb1-glaucoma-obesity-weight-loss-metabolic-nimacimab/#respond Tue, 11 Jun 2024 00:15:04 +0000 https://medcitynews.com/?p=127166

Skye Bioscience’s nimacimab blocks CB1, the same receptor targeted by an obesity drug candidate now in the hands of Novo Nordisk. But Skye contends its Phase 2-ready antibody drug has several advantages over the small molecule that joined Novo’s pipeline in a deal valued at $1 billion.

The post Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program appeared first on MedCity News.

]]> https://medcitynews.com/2024/06/skye-bioscience-cb1-glaucoma-obesity-weight-loss-metabolic-nimacimab/feed/ 0 127166 GW’s cannabinoid-based Epidiolex scores another Phase III epilepsy victory https://medcitynews.com/2019/05/gws-cannabinoid-based-epidiolex-scores-another-phase-iii-epilepsy-victory/ Tue, 07 May 2019 19:53:48 +0000 https://medcitynews.com/?p=457820

The drug showed positive results in a 210-patient study in patients experiencing treatment-resistant seizures from tuberous sclerosis complex, a rare form of epilepsy.

The post GW’s cannabinoid-based Epidiolex scores another Phase III epilepsy victory appeared first on MedCity News.

]]> 78410 Taking the fun out of weed, but addressing unmet need: Startup refining cannabinoids for therapeutic use https://medcitynews.com/2015/04/taking-fun-weed-addressing-unmet-need-startup-refining-cannabinoids-therapeutic-use/ Fri, 24 Apr 2015 14:00:01 +0000 https://medcitynews.com/?p=332165 Los Angeles startup Kalytera Therapeutics is taking the high out of the THC – refining cannabinoids so they can have broader therapeutic applications in conditions like osteoporosis, Prader-Willi syndrome, PTSD, obesity and weight loss associated with cancer. Kalytera just raised $500,000 in seed funding, according to a regulatory filing. There’s a litany of potential applications for […]

The post Taking the fun out of weed, but addressing unmet need: Startup refining cannabinoids for therapeutic use appeared first on MedCity News.

]]> 68605